INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025

Core Viewpoint - INVO Fertility, Inc. announced a 1-for-3 reverse stock split to comply with Nasdaq's minimum bid price requirement, effective July 21, 2025 [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 3 shares of common stock into 1 share, rounding up any fractional shares [2]. - Post-split, the company will have approximately 928,272 shares issued and outstanding, with authorized shares adjusted to 1,388,888 [2]. Group 2: Company Overview - INVO Fertility is focused on expanding assisted reproductive technology (ART) care, operating fertility clinics, and distributing its proprietary INVOcell medical device [4]. - The INVOcell device allows fertilization and early embryo development to occur in vivo, offering a more natural and cost-effective alternative to traditional IVF [4].